View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-0009
ICR Reference No:
201708-0920-015
Status:
Historical Active
Previous ICR Reference No:
201601-0920-001
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-0009 (17AXX)
Title:
National Disease Surveillance Program
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
09/13/2017
Retrieve Notice of Action (NOA)
Date Received in OIRA:
08/16/2017
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
06/30/2019
06/30/2019
06/30/2019
Responses
630
0
630
Time Burden (Hours)
173
0
190
Cost Burden (Dollars)
0
0
0
Abstract:
Since 2014, state and local health departments, in consultation with clinicians, have submitted information about suspect cases to CDC. However, CDC has received feedback from the state and local health departments and clinicians about the feasibility of completing the requested information on the currently approved Acute Flaccid Myelitis Patient Summary Form. In order to decrease the overall burden to complete the form, CDC has deleted the clinical sections on the form and in turn, requests the respondents supplement that clinical information with clinical notes, MRI reports, and images.
Authorizing Statute(s):
US Code:
42 USC 241
Name of Law: Research and Investigations Generally
US Code:
42 USC 301
Name of Law: General Powers and Duties of Public Health Service
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
80 FR 56997
09/21/2015
30-day Notice:
Federal Register Citation:
Citation Date:
80 FR 78737
12/17/2015
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
4
IC Title
Form No.
Form Name
Att D-1_CJD
Att D-3_Reye Syndrome
Att D-4_Acute Flaccid Myelitis
0920-0009 (17AXX)
Non-substantive Change 0920-0009_Acute Flaccid Myelitis Patient Summary Form Final 7272017
Att D2_Kawasaki Syndrome
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
630
630
0
0
0
0
Annual Time Burden (Hours)
173
190
0
-17
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Changing Forms
Short Statement:
In order to decrease the overall burden to complete the form, CDC has deleted the clinical sections on the form and in turn, requests the respondents supplement that clinical information with clinical notes, MRI reports, and images.The Acute Flaccid Myelitis: Patient Summary Form format change reduces the total burden hours from 50 to 33 hours because the average burden per response to complete the form is reduced from 30 minutes to 20 minutes.
Annual Cost to Federal Government:
$10,000
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
Yes
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Catina Conner 4046394775
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
08/16/2017